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Department of General Psychology, University of Padua, Padova, Italy
Aim:Major depressive episode (MDE) can manifest with different features. Discriminating
between different types of MDEs is crucial for proper treatment. The aim of this study is
to propose a new tool for MDE assessment in bipolar disorder (BD) or major depressive
disorder (MDD) to overcome some limitations of current rating scales. The proposed tool
investigates all of the clinical features of different MDEs and gives qualitative information,
differentiating patients with the same score but different symptoms and psychopathology
severity. To achieve this purpose authors used a new methodology called Formal
Psychological Assessment (FPA). FPA allows creating relations between the items of an
assessment tool, and the set of diagnostic criteria of a given clinical disorder. In the
application at hand, given the capability to analyze all clinical features, FPA appears
a useful way to highlight and differentiate between inhibited and agitated depressive
symptoms.
Method: The new tool contains 41 items constructed through 23 clinical criteria from the
DSM-5 and literature symptoms. In line with FPA, starting from a set of items and a set
of clinical criteria, a Boolean matrix was built assigning to each item its own set of clinical
criteria. The participants include 265 in the control group and 38 patients with MDE
(diagnosed with MDD or BD) who answered the QuEDS. After 1 month, 63 participants
performed the test again and 113 took the Depression-Anxiety-Stress Scale to analyze
convergent—divergent validity.
Results: The scale showed adequate reliability and validity. A hierarchical confirmatory
factor analysis highlighted the presence of three sub factors (affective, somatic, and
cognitive) and one high-order factor (depression).
Conclusions: The new tool is potentially able to inform clinicians about the patients’
most likely diagnostic configuration. Indeed, the clinical state of a patient consists of
the subset of items he/she answered affirmatively, along with his/her subset of specific
symptoms. Qualitative information is fundamental from a clinical perspective, allowing
for the analysis and treatment of each patient according to his/her symptoms in an
effective way.
Keywords: major depressive episode, questionnaire, formal psychological assessment, symptomatology,
psychopathology, quantitative-qualitative evaluation
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INTRODUCTION
Clinical evaluation and treatment may have different aims; in
fact, psychologists and psychiatrists face many forms of suffering
and discomfort. The case formulation is obtained by collecting
all necessary data, which allows clinicians to reconstruct the
mechanisms and processes underlying the disorders presented,
agree on treatment goals, and to identify the most appropriate
therapy in an effective way (Grossberg, 1964; Groth-Marnat,
2009; Bokhari and Hubert, 2015).
Even after following the relevant steps of assessment research,
some critical issues still exist. Specifically, the tools for
evaluating mood disorders, particularly those involving major
depressive episodes (MDEs) ones, show some application limits.
Some studies highlighted critical issues regarding self-report
depression tools and this is crucial for assessment and treatment
(Baldessarini et al., 2010; Hyman, 2014).
Pettersson et al. (2015) conducted a systematic review on
evaluating depression, which revealed that only the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I;
First et al., 1995), the Mini-International Neuropsychiatric
Interview (MINI; Sheehan et al., 1998), and the Patient Health
Questionnaire (PHQ-9;Manea et al., 2012) fulfilled theminimum
criteria for sensitivity and specificity. Out of these three tools,
only the PHQ-9 is a self-report measure that can be used for
screening, diagnosis, monitoring, and measuring the severity of
depression.
In a critical study, Balsamo and Saggino (2007) introduced
the psychometric strengths and weaknesses of the most
important self-assessment measures of depression. The purpose
was to avoid confusion in clinical practice. Specifically, the
study explored the psychometric properties of six self-report
measures of depression: the Beck Depression Inventory-II
(BDI-II; Beck et al., 1988); the Center for Epidemiological
Studies Depression Scale (CES-D; Radloff, 1977); the Zung Self-
Rating Depression Scale (Sakamoto et al., 1998); the Clinical
Depression Questionnaire (CDQ; Krug and Laughlin, 1976); the
Questionnaire for Depression (QD), included in the Cognitive
Behavioral Assessment 2.0 battery (CBA 2.0; Sanavio et al.,
1986); and the D scale of the Minnesota Multiphasic Personality
Inventory (MMPI; Hathaway and McKinley, 1942). Balsamo and
Saggino (2007) showed that patients overestimate symptoms,
perhaps because of their mental condition; another observed
limitation was that each scale reflects the authors’ theories,
which were constructed to measure different aspects of the same
construct.
A study of seven widely used self-report measures on
depression (Serra et al., 2015) highlighted the weaknesses of
these tools in relation to their ability to investigate all of the
diagnostic criteria for MDE described by the DSM-5 and a
large amount of literature. Attention was focused on seven self-
assessment questionnaires: the BDI-II (Beck et al., 1996), the
SDS (Zung et al., 1965), the Rome Depression Inventory (RDI;
Pancheri and Carilli, 1982), the Plutchik–Van Praag self-report
depression scale (PVP; Plutchik and Van Praag, 1987), the Carroll
Rating Scale (CRS; Carroll et al., 1981), the Self-Assessment
Scale for Depression (SAD; Cassano and Castrogiovanni, 1982),
and finally, the Center for Epidemiological Studies Depression
scale (CES-D; Eaton et al., 2004; Shean and Baldwin, 2012).
Different tools measure different aspects of depression (cognitive,
emotional, physiological, etc.); therefore, it is important to know
which aspects a depression scale is able to identify. This study
reported that none of the seven tools investigates the integration
of clinical criteria by itself.
Dobson (1985) found poor discriminant validity between
depression and anxiety, highlighting the high correlation (around
0.61) among the different tools for measuring depression and
anxiety.
Gibbons et al. (1985) emphasized that the traditional method
of scoring can be “wrong” because it is based on assumptions that
may be false: it gives equal weight to each item, assuming that
each item or symptom of a clinical scale represents an equal level
of psychiatric severity.
Moreover, as many authors have underlined, self-evaluating
questionnaires allow for a systematic and quick collection of
a large amount of information and the avoidance of patient
embarrassment; on the other hand, they redundantly (non-
adaptively) investigate constructs and provide only a quantitative
numeric score that does not systematically account for qualitative
information (Shapiro, 1951; Wright and Feinstein, 1982; Fava
et al., 2004; Spoto et al., 2013; Bottesi et al., 2015b).
Based on the assumptions of the studies described above,
it is important to consider all of the limits that self-report
tools have, by taking into account the possible overestimation
of symptoms by patients (Faravelli et al., 1986; Balsamo and
Saggino, 2007), the high comorbidity between depression and
anxiety (Dobson, 1985), and the inability of MDE self-report
measures to enclose the whole set of depressive symptoms,
whether agitated or inhibited (Koukopoulos and Koukopoulos,
1999; Serra et al., 2015), in the construction of the item (including
the PHQ-9-Sensitive estimated in Petterson’s review). Finally, it
is also relevant to remember not to take into account only the
patient’s cutoff scores (Gibbons et al., 1985; Fava et al., 2004;
Bottesi et al., 2015b). As a consequence of the last statement,
even overtaking or not overtaking the cutoffmay not always be so
important. In fact, the cutoff provides only a quantitative score,
but if two patients have the same score, it does not mean that they
have equal symptomatology (one could be much more serious
than the other, since he/she responded positively to more severe
symptoms).
The purpose of this study is to create a new tool for
MDE evaluation to overcome the difficulties of the MDE
tools described above. The present study aims to construct
an adaptive-qualitative tool that investigates all MDE clinical
features and provides qualitative information (and not just a
score) to differentiate patients with the same score but different
symptoms as well as differing severities of psychopathology.
From a conceptual point of view, depression is a strong and
united construct; some authors, including Beck, attributed more
importance to the cognitive dimension of depression (Rainone
and Mancini, 2007) without neglecting the somatic-affective
dimension. Many authors identified three dimensions in the
depression construct: cognitive, somatic, and affective (O’Hara
et al., 1984; Roca et al., 1996; Dinger et al., 2015). A hierarchical
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model having three subdimensions (namely: cognitive, affective
and somatic) and one second order factor (depression) could be
the factorial solution that is most likely to represent the structure
of the investigated construct; in fact, this model would have the
advantage of offering an interesting explanation, from the clinical
perspective.
One possibility to overcome some of the assessment
limitations and therefore to build up this new tool is a new
methodology called Formal Psychological Assessment (FPA;
Spoto et al., 2010, 2013; Bottesi et al., 2015b; Serra et al.,
2015). FPA tries to maximize the advantages of both self-
report tests and semi-structured interviews. The FPA was born
as an extension to the CBA-2.0 (Bertolotti et al., 1990) and
developed in an original way from the conjunction of two
mathematical psychology theories and a consequent innovative
clinical application: Knowledge Spaces Theory (KST; Doignon
and Falmagne, 1985, 1999; Falmagne and Doignon, 2011) and
Formal Concept Analysis (FCA; Wille, 1982; Ganter and Wille,
1999). FPA allows the detection and fruitful use of relations
among a set of items (objects) from any clinical tool and
a particular set of diagnostic criteria (attributes) for a given
clinical disorder. Below some key concepts of this approach are
described.
In FPA, each item included in a clinical self-report
questionnaire (or interview) is defined as an object. Each item
can be described on the basis of a set of elements (symptoms)
referring to a given theoretical framework. These symptoms
come from the decomposition of the diagnostic criteria from
the DSM-5 (American Psychiatric Association, 2013) for a given
disorder, or from additional clinical criteria derived from the
literature with respect to a particular clinical disorder. The
symptoms are named attributes, and each object can be related to
the set of attributes it endorses. Each item may investigate one or
more attributes (symptoms), and each attribute can characterize
one or more items. For example, a hypothetical item “I have
sleep problems” investigates the attribute insomnia or iper-somnia
(DSM-5, major depressive episode). Starting from a set of items
and a set of attributes, a Boolean matrix can be built that assigns
to each item its own set of clinical criteria (attribute). The items
are placed in the rows of the matrix, and the attributes are
placed in the columns. Every time an item investigates a specific
attribute, the corresponding cell of the matrix will contain “1”;
otherwise, the cell will contain “0” (Spoto et al., 2013; Bottesi
et al., 2015b; Serra et al., 2015). In FPA, this matrix represents
the clinical context. The entire set of item of a clinical tool is the
domain of the clinical context. A patient’s clinical state consists
of the subset of items he/she answered affirmatively. Thus, even
if two patients respond affirmatively to the same number of
items (i.e., they obtain the same score in the questionnaire),
the representation of their two states in terms of attributes will
be different, if the items they answered affirmatively are also
different. The clinical structure represents the relationship among
the items of the domain. The implications of the items form
prerequisite relations. The prerequisite is an item that contains
the same attribute “a” of another item that contains the same
attribute “a” and one or more (for example “b”). In total, the
second item will contain “a” and “b.” The first item is necessary to
get a positive answer to the second item. The prerequisite relation
among the items obtained from the matrix through the formal
mathematical passages can lead to the development of adaptive
and qualitative tools as well as quantitative tools (Spoto et al.,
2010; Donadello et al., 2016).
The paper is organized as follows: in the next section is
described the tool construction, including the choice of the
clinical criteria and the construction of the items. In that section
are provided also the methodological details about the sample,
the procedure and the data analysis. In Section Results, results
of the psychometric study regarding the reliability and validity
of the new tool are displayed, together with two clinical cases
examples highlighting the specific improvement in the collected
information allowed by the new tool. Future perspectives,
limitations and strengths of the present study are finally discussed
in Section Discussion.
MATERIALS AND METHODS
Tool Construction
Three important steps were achieved in constructing the new
tool:
1. Various features and symptoms (clinical criteria) of MDEs
were analyzed and categorized as attributes. As described in
the DSM-5 (American Psychiatric Association, 2013), there
are different types of MDEs; in particular, a MDE may be
reactive (due to bereavement or trauma) or have a biological
basis, and it can be part of MDD or bipolar disorder (BD, Type
I or II), with symptoms more agitated or more inhibited.
2. The items were constructed on the basis of one ormore chosen
clinical criteria (attributes).
3. In line with the FPA methodology, the matrix was obtained
to analyze all of the relationships among items (objects) and
diagnostic criteria (attributes). More specifically, the items of
the tool were verified as covering the entire set of clinical
criteria (all columns contained at least one “1”). This result was
achieved through the agreement of four specialists in the field
of mood disorders selected on the basis of their expertise in the
field of CBT and psychological assessment. More specifically,
experts were asked to fill independently a Boolean matrix with
the items in rows and the attributes in columns. Whenever
an item, in their opinion, investigated a specific attribute,
the corresponding cell in the matrix should have been filled
with 1, otherwise with 0. Experts were not allowed to propose
new items or new attributes. The Cohen’s κ coefficient was
computed for each pair of experts’ matrices and resulted in
an average value of 0.88 indicating a very good agreement
among experts. The remaining disagreements were discussed
and solved by means of a focus group.
Table 1 summarizes all of the sets of clinical criteria that we
considered in constructing the MDE assessment tool.
First of all, MDE is described by the decomposition of the
DSM-5 diagnostic criteria (American Psychiatric Association,
2013) for this disorder (it may be part of both MDD and BD);
then, all of the described clinical criteria were taken into account:
A1 (depressed mood), A2 (diminished interest and pleasure), A3
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TABLE 1 | The 23 clinical criteria for major depressive episode construct.
Attribute Explanation
A1 Depressed mood
A2 Diminished interest and pleasure
A3 Decreased interest in sex
A4 Increase or loss of weight
A5 Gain or loss of appetite
A6 Insomnia or hypersomnia
A7 Agitation
A8 Psychomotor retardation
A9 Fatigue or energy loss
A10 Feelings of worthlessness (or Beck’s negative view of self)
A11 Feelings of guilt
A12 Diminished ability to think and concentrate
A13 Indecision
A14 Recurrent thoughts of death
A15 Suicidal ideation or attempted suicide
A16 Beck’s negative view of the world
A17 Beck’s negative expectation of the future
A18 Seligman’s learned helplessness
A19 Irritability
A20 Apathy
A21 Health concern
A22 Somatic disorders
A23 More positive mood in the evening
(decreased interest in sex), A4 (increase or loss of weight), A5
(gain or loss of appetite), A6 (insomnia or hypersomnia), A7
(agitation), A8 (psychomotor retardation), A9 (fatigue or energy
loss), A10 (feelings of worthlessness), A11 (feelings of guilt), A12
(diminished ability to think and concentrate), A13 (indecision),
A14 (recurrent thoughts of death), and A15 (suicidal ideation or
attempted suicide).
Criterion A15 underlines the seriousness of “suicidal ideation”
in MDE and is obviously the most severe symptom (Balázs
et al., 2006; Batterham et al., 2015). It has been decided to
separate this symptom by thoughts of death. According to several
authors, suicide is indeed the third-highest cause of death in the
population between 15 and 35 years old (Gunnell andMiddleton,
2003; Baldessarini et al., 2006).
Furthermore, attributes A16, A17, and A18 are related
to two theories of cognitive behavioral matrices, which led
to the development of psychotherapeutic techniques that are
now widely used: Beck’s hopelessness theory and Seligman’s
helplessness theory.
(a) Beck’s hopelessness theory. Beck’s (1991; 2005) model
contains persistent structural representations of human
experience called schemes, which direct the identification,
interpretation, classification, and evaluation of experiences.
The schemes are structurally rigid, resistant, and absolute,
and their content is a distorted representation of the
experience. A negative view of oneself is a central feature
of depression, and the real information about people’s skills
in various areas are distorted; also, patients with depression
often have distorted evaluations of such events, as a result
of the intervention of different processes called “cognitive
distortions.”
Beck found that beliefs and typical cognitive errors of
depression are related to a “cognitive triad”:
• A negative view of oneself in terms of personal value (“I
am a loser”; “I am a failure”) and in terms of kindness and
esteem of others (“nobody loves me”; “I’m not a person
worthy of love”). The corresponding criterion has just
been included in the DSM-5 criteria (A10).
• A negative view of the world (“the world is a bad and
unfortunate place”; “others take advantage of me”; “life is
unfair toward me”); the corresponding criterion is A16.
• A negative expectation about the future (“it will not change
anything”; “I will always be a loser”); the corresponding
criterion is A17.
(b) Seligman’s learned helplessness theory. Seligman (1972),
in an analogy with observations of dogs, suggested that
among depressed men with depression, there is a learned
conviction that they cannot do anything to face stressful
life events and, as a consequence, they passively accept
the outcome of those events (Alloy et al., 1984). This
attitude tends to be generalized to new situations because
of negative expectations, with people developing a sense
of learned helplessness at the cognitive level. The criterion
corresponding to this theory is A18.
On the basis of a careful literature review, other clinical criteria
for MDE were taken into account because they are often part of
depressive symptoms, even in the absence of comorbidity with
other disorders of Axis I (Goodwin and Jamison, 2007). These
symptoms are widely described in the literature, and they are
potentially able to discriminate between different types of MDEs:
Criterion A19 refers to irritability (Henderson et al., 2013;
Pedrelli et al., 2013); a person with depression can easily feel
frustrated, and this frustration often results in outbursts of anger.
Criterion A20 refers to apathy (Mulin et al., 2011; Alexopoulos
et al., 2013). Patients with depression often are characterized
by decreased emotional reactions to situations and events in
everyday life. Apathy is expressed in the form of indifference,
physical inertia, or lack of reaction when facing situations that
would normally arouse interest or emotion, as well as a reduction
of purposeful behavior, a lack of initiative, and submission in
one’s daily choices.
Criterion A21 refers to health concerns (House, 1989;
Magariños et al., 2002). It can take on the characteristics of
real hypochondria in MDE, and the concerns may be related to
somatization disorders.
Criterion A22 refers to somatic disorders (Goodwin and
Jamison, 2007; Al Busaidi, 2010; Campo, 2012), which can be
expressed through a myriad of symptoms in people with MDE,
including neurovegetative disorders, stomach cramps, vomiting,
difficulty of digestion, diarrhea, palpitations, hyperventilation,
paresthesia, sweating, flushing, tremors, headaches, increased
heart rate, an urgent need to urinate often, a feeling of
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heaviness in the limbs or in the head, and back or muscle
pain.
Criterion A23 was inserted as the last in the list of clinical
criteria for assessingMDE. The literature review and the presence
of this attribute in the items of almost all MDE scales analyzed
by Serra et al. (2015) demonstrate its important contribution
to depression evaluation. In fact, individuals with depression
usually feel better at the end of the day when they can go to sleep
and do not have to face their daily problems anymore.
These last five symptoms are present in many rating
scales of depression (Serra et al., 2015). These symptoms are
useful to differentiate symptomatology; in addition to agitated
depression and more inhibited depression, other authors have
differentiated “anaclitic depression,” with feelings of loneliness
and abandonment, from “introjective depression,” with feelings
of failure and worthlessness (i.e., Blatt, 2004).
On the base of the criteria described above, 41 items have
been constructed. Some of them contain a single diagnostic
criterion; for example, the item “I feel helpless in the face of
life events” contains A18—the learned helplessness of Seligman.
Other items were constructed to include two or more diagnostic
criteria; for example, the item “I feel nervous about this sadness I
never abandon” contains three diagnostic criteria: A17—Beck’s
negative expectation of the future, A1—depressed mood, and
A7—agitation. In line with the FPAmethodology, the matrix was
built to analyze all of the relationships among these items and
diagnostic criteria. The whole set of clinical criteria (attributes)
in Table 1 were investigated by the set of 41 items. This tool goes
beyond the score of the patient and investigates the diagnostic
features implicated by the answers that an individual has given
(Spoto et al., 2013; Bottesi et al., 2015b; Serra et al., 2015). The
investigation of diagnostic features is fundamental from a clinical
point of view, since it allows for personalized diagnosis, which
could have a role in treatment decisions and strategies, since
the psychological and pharmacological treatment of agitated
depression is different from that of inhibited depression. This
new perspective is more deeply explored in the Results and
Discussion sections.
Participants
The research participants who were tested were divided into
clinical and non-clinical groups.
The clinical group consisted of 38 subjects with MDE (who
were diagnosed with MDD or bipolar disorder, or else with MDE
during their first access in the day hospital) of the Neurosciences,
Mental Health, and Sensory Organ (NESMOS) Department of La
Sapienza University, Rome. In particular, the patients included
in the study comprised eight individuals who were on their first
access to the day hospital, four people who had a reactive MDE
(caused by a stressful event or a death event), two who had an
MDE with familiar genetics in mood disorders highlighted by
their medical history, and two who suffered from unspecified
MDE. Eleven patients were suffering from MDE within a major
depressive disorder; one patient of this group had comorbid
obsessive compulsive disorder (OCD), one patient had comorbid
social anxiety disorder, and two others had comorbid eating
disorder (anorexia nervosa). Nine patients were suffering from
an MDE within bipolar disorder type 1; two of them had
comorbid OCD, and two other patients had comorbid eating
disorder (anorexia nervosa and bulimia). Finally, ten patients
were suffering from MDE in bipolar disorder type 2; three of
them had comorbid OCD, two of them had comorbid panic
disorder, and one of them had comorbid social anxiety disorder.
The exclusion criteria were mental retardation and psychotic
traits to avoid problems in interpreting the responses to the
QuEDS. Of the participants, 47% were male and the remaining
53%were female. Amajority of the participants had a high school
diploma, and their ages ranged between 21 and 69 years.
The non-clinical group consisted of 265 Italian individuals
from different regions. The convenience non-clinical sample of
the present research included individuals recruited in the area
of the University of Padova (both students and non-students).
The exclusion criteria in the non-clinical group involved all
individuals suffering from MDE (e.g., those who were under
pharmacological or psychotherapeutic treatment for depression).
Among these participants, 70% were female. A majority of
participants had a high school diploma, and their ages ranged
between 19 and 56 years.
Clinical Tools
The Qualitative—Quantitative Evaluation of
Depressive Symptomatology (QuEDS)
The QuEDS tool contains 41 dichotomous items constructed on
the basis of 23 clinical criteria of major depressive episodes from
the DSM-5 and the literature. It is composed of 41 items; the
maximum score is 41, and the minimum is 0. It is assumed that
if a person responds positively to an item, then he/she has the
symptoms (in terms of clinical criteria or attributes) included in
this item.
Depression-Anxiety-Stress-Scale 21 (DASS-21)
The DASS-21 is the short version of the self-report test designed
to measure the three related negative emotional states of
depression, anxiety, and stress (Henry and Crawford, 2005;
Bottesi et al., 2015a). DASS-21 contains seven items for assessing
depression seven items for assessing anxiety and seven items
for assessing stress. The Depression scale evaluates dysphoria,
hopelessness, devaluation of life, self-deprecation, a lack of
interest/involvement, anhedonia, and inertia. The Anxiety scale
assesses autonomic arousal, situational anxiety, and subjective
experience of anxious affect. The Stress scale (items) is sensitive
to levels of chronic non-specific arousal. It assesses difficulty in
relaxing as well as being easily agitated, irritable, and impatient.
The respondents are asked to use a 4-point Likert scale to indicate
the severity and frequency of symptoms.
Procedure and Administration
All of the research participants completed informed consent
and sociodemographic forms before answering the questionnaire
items. No time limit was imposed to complete the questionnaires.
All 265 subjects of the non-clinical group completed the QuEDS
for major depressive episodes.
A subgroup of 113 individuals of the non-clinical group
also answered the self-report measure DASS-21 to evaluate the
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convergent and divergent validity of the QuEDS. Moreover, 63
out of these 113 subjects compiled the QuEDS twice, after 1
month, to evaluate the temporal stability of the scale (test–retest).
The clinical group responded to the QuEDS, after being tested
on their depressive symptomatology through a depression rating
scale (SCID-I) and diagnosed as MDE patients by NESMOS
Department’s psychiatrists.
At clinic intake, participants provided written, informed
consent for potential research analysis and anonymous reporting
of clinical findings in aggregate form, in accord with Italian legal
and ethical requirements. For this reason an ethics review process
is not needed for these non-invasive clinical studies.
The study was conducted in accordance with the Declaration
of Helsinki. All participants entered the study of their own free
will and provided their informed consent before taking part. They
were informed in detail about the aims of the study, the voluntary
nature of their participation, and their right to withdraw from
the study at any time and without being penalized in any way.
Furthermore, participants were allowed to ask for restitution
about their own score, providing authors with their own auto
generated code, used during the administration phase.
Data Analysis
The whole sample (N = 303) was composed by a non-clinical
subsample (N = 265) and a clinical subsample (N = 38), no
missing data were observed. Different kinds of data analyses
were conducted to test the validity and reliability of the QuEDS.
Inferential analyses were conducted by means of the software R
3.3.0 (R Core Team, 2013), while confirmatory factor analysis
(CFA) was conducted by means of the software LISREL 8.80
(Jöreskog and Sörbom, 1986, 1989, 1993; Jöreskog, 2006).
Known-groups validity was evaluated by means of both a
comparison between the scores of non-clinical group (N = 265)
and clinical group (N = 38), and referring to the classical ROC
curves approach on the whole sample.
The data of non-clinical participants (N = 265) were used
to fit a hierarchical model with three sub-factors and a higher-
level factor (depression). This model was compared to other three
possible factorial structures using the data of the entire non-
clinical subsample (N = 265). Convergent validity was evaluated
by computing the correlation between the QuEDS and the DASS-
21 scores using the data of 113 participants of the non-clinical
subsample. The reliability of the scale was tested both with respect
to the internal consistency and to the test-retest. For the internal
consistency the data of all non-clinical participants (N = 265)
were used, while, for the test retest, were used 63 participants of
the non-clinical subsample. Content validity has been evaluated
by referring to the FPA methodology. Finally, again by means
of the FPA, the capability of the tool to clinically discriminate
patients has been tested and reported.
RESULTS
Construct Validity
The construct validity of the QuEDS was evaluated by
investigating its factorial validity and convergent–divergent
validity.
Factorial Validity
As described above, a hierarchical model could be the factorial
solution that is most likely to represent the structure of the
investigated construct. Since the QuEDS was constructed both
specifically for evaluating depressive symptoms and sensitively
to evaluate thoughts (cognitive), somatic aspects (somatic), and
emotions (affective) related to depression, authors are interested
in testing, on the non-clinical sample—N = 265— (Osborne and
Costello, 2004; Garson, 2008), a hierarchical factorial structure
(Berrios et al., 2015; Roberts et al., 2015) with three sub-factors
(i.e., cognitive, affective, and somatic), all linked to a second-
order factor (i.e., depression). Furthermore, in order to compare
the fit of this model to different theoretically plausible solutions,
it was compared with three other different factorial models to the
collected data: (a) a model with one latent construct which we
called depression; (b) a model with two latent factors, which we
called the somatic-affective factor and cognitive factor; and (c) a
model with three factors: cognitive, somatic and affective factors.
In the proposed hierarchical model, the items were grouped
into the sub-factors as follows:
• The cognitive factor includes items 5, 6, 9, 10, 14, 19, 20, 21,
24, 25, 27, 30, 32, 33, and 41. It comprises symptoms related to
the distortions of thought systems and also to feelings of guilt,
helplessness, worthlessness, hopelessness, and death.
• The somatic factor includes items 1, 2, 3, 4, 11, 13, 16, 22, 23,
26, 28, 31, 35, and 39. It comprises symptoms related to fatigue,
sleep, appetite, psycho-motor retardation, and other somatic
disorders that often involve MDEs.
• The affective factor includes items 7, 8, 12, 15, 17, 18, 29, 34,
36, 37, 38, and 40. It comprises the emotions that characterize
different types of MDEs, including sadness (common in all
subtypes of MDE), apathy, irritability, agitation, and various
concerns.
Table 2 displays a comparison of the fit indexes for the four
tested factorial structures. The table shows that the hierarchical
model fits the data better than any of the three other models.
All of the fit indexes for the hierarchical model (with no use
of modification indexes) had adequate values. More specifically,
the ratio between the Chi-square and the degrees of freedom,
the RMSEA, the CFI, and the NNFI showed a good fit, while
the NFI indicated an adequate model fit (Marsh et al., 2004).
Furthermore, no significant double loadings were observed, nor
correlation among error terms.
For the hierarchical model, all of the items’ saturations on
the respective factors were significant and ranged between 0.26
and 0.76 for the cognitive factor; between 0.32 and 0.71 for the
somatic factor; and between 0.33 and 0.70 for the affective factor
(Table 3).
The results support the selection of the hierarchical model
by confirming that its underlying factorial structure has a
higher-order factor accounting for the relationship among lower-
order specific factors (Subica et al., 2014). In second-order
models, it is necessary for the lower-order specific factors to
be correlated among each other and with the higher-order
factor (Schmid and Leiman, 1957). In this specific case, the
links between the sub-factors and the higher-order factor were
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TABLE 2 | The fit indexes of the four tested models.
Fit index Mono-factorial Two-factor
model
Three-factor
model
Hierarchical
model
χ
2/df 2.07 1.85 1.83 1.75
RMSEA 0.064 0.057 0.056 0.053
NFI 0.84 0.86 0.86 0.87
NNFI 0.91 0.93 0.93 0.94
CFI 0.91 0.93 0.93 0.94
SRMR 0.103 0.094 0.092 0.084
AIC 1,775 1,603 1,591 1,532
in the range of 0.70–0.91, once more supporting the selected
model.
Convergent–Divergent Validity
The convergent validity of the QuEDS was verified by comparing
its scores in the non-clinical sample with those of the DASS-21
(which, as described above, is constituted by three sub-scores
for Depression, Anxiety, and Stress). The correlations among the
113 subjects’ scores in the QuEDS and the three sub-scales of
DASS-21 were all significant. More specifically, the correlation
between the QuEDS and the Depression subscale of the DASS-
21 was r = 0.72 (p < 0.05); the correlation between the QuEDS
and the Anxiety subscale of the DASS-21 was r = 0.39 (p< 0.05);
and the correlation between the QuEDS and the Stress subscale
of the DASS-21 was r = 0.59 (p < 0.05). These results are
not surprising, since the depression construct may have several
features in common with the stress and anxiety constructs.
However, it has to be stressed that the correlation between the
QuEDS and the Depression subscale was significantly higher than
the correlation between the QuEDS and the Anxiety subscale
(z = 3.32, p< 0.001); on the contrary, a not significant difference
was observed between the correlation of the QuEDS with the
Depression subscale and the correlation of the QuEDS and the
Stress subscale (z = 1.71, n.s.). These results are different from
what Dobson (1985) found and indicate a good divergent validity
of the QuEDS with respect to tools measuring different but
correlated constructs.
The correlations among the sub-factors (cognitive-somatic-
affective) of the QuEDS and the subscales of the DASS-21 have
also been computed, and the results are displayed in Table 4.
While the correlation between the Anxiety subscale of the
DASS-21 and the factors of the QuEDS was systematically and
significantly lower than the correlations between the QuEDS
subscales and the Depression subscale of the DASS-21 (cognitive:
z= 2.57, p< 0.01; somatic: z= 2.24, p< 0.05; affective: z= 2.03,
p < 0.05), the situation was the opposite with respect to the
Stress subscale. In fact, all the correlations between the three sub
factors of the QuEDS and the Depression subscale of the DASS-
21 were not significantly higher than their correlation with the
Stress subscale (cognitive: z = 1.65, n.s., somatic: z = 1.23, n.s.;
affective: z = −0.11, n.s.). Table 4 displays the 7 × 7 correlation
matrix of the QuEDS total score, QuEDS subscales, and the three
subscales from the DASS-21.
TABLE 3 | Factor loadings of each of the 41 items of the QuEDS.
Cognitive factor Somatic factor Affective factor
Item 5 0.59 – –
Item 6 0.37 – –
Item 9 0.50 – –
Item 10 0.42 – –
Item 14 0.72 – –
Item 19 0.32 – –
Item 20 0.62 – –
Item 21 0.37 – –
Item 24 0.66 – –
Item 25 0.64 – –
Item 27 0.26 – –
Item 30 0.51 – –
Item 32 0.62 – –
Item 33 0.26 – –
Item 41 0.76 – –
Item 1 – 0.32 –
Item 2 – 0.46 –
Item 3 – 0.59 –
Item 4 – 0.37 –
Item 11 – 0.34 –
Item 13 – 0.42 –
Item 16 – 0.61 –
Item 22 – 0.39 –
Item 23 – 0.36 –
Item 26 – 0.42 –
Item 28 – 0.71 –
Item 31 – 0.55 –
Item 35 – 0.54 –
Item 39 – 0.39 –
Item 7 – – 0.36
Item 8 – – 0.39
Item 12 – – 0.49
Item 15 – – 0.45
Item 17 – – 0.45
Item 18 – – 0.62
Item 29 – – 0.38
Item 34 – – 0.70
Item 36 – – 0.46
Item 37 – – 0.65
Item 38 – – 0.53
Item 40 – – 0.33
Depression 0.77 0.70 0.91
No double loading were observed. In the last line of the table are displayed the strengths
of the links between the first and second-order factors.
Known-Groups Criterion Validity
The scores of 38 patients with MDE were compared with those
of the 265 non-clinical subjects to test the known-groups validity
of the QuEDS. The clinical group obtained an average score of
28.5 (sd = 6.5), while the non-clinical group obtained an average
score of 6.5 (sd = 6). The difference between the two groups,
tested using a t-test for independent samples, was significant
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TABLE 4 | The correlation matrix of the three subscales from the DASS-21, the three subscales of the QuEDS, and the total score of the QuEDS.
DASS-21 depression DASS-21 anxiety DASS-21 stress QuEDS-cognitive QuEDS-somatic QuEDS-affective QuEDS-TOT
DASS-21 depression –
DASS-21 anxiety 0.37 –
DASS-21 stress 0.44 0.50 –
QuEDS-cognitive 0.64 0.37 0.48 –
QuEDS-somatic 0.53 0.25 0.40 0.37 –
QuEDS-affective 0.58 0.34 0.56 0.61 0.46 –
QuEDS-TOT 0.72 0.39 0.59 0.80 0.78 0.84 –
(t299 = −20.20; p < 0.001) and supported the validity of the
QuEDS. Furthermore, in order to test the ability of the QuEDS
in separating the two groups, an analysis based on the ROC
curves has been carried out. Results showed a very good value
of the AUC statistic (confidence interval 0.97–0.99). Moreover,
an optimal threshold score of 19 was determined that allowed for
a specificity of 0.98 and a sensitivity of 0.94.
Reliability
A reliability analysis, on the non-clinical sample, showed that the
QuEDS scale has a very good internal consistency, Cronbach’s
α = 0.948. Even the alpha values relative to the three sub-
factors were good: cognitive factor (α = 0.91; average item
intercorrelation = 0.41), somatic factor (α = 0.86; average
item intercorrelation = 0.31), affective factor (α = 0.82; average
item intercorrelation= 0.41). Given such values and the number
of items in the scale the alpha precision can be considered
adequate (Cortina, 1993). Regarding the test–retest reliability
of the QuEDS, the correlation among the scores of the 63 test
subjects at Time 1 and Time 2 (after 1 month) was 0.74, which
indicates good stability for the tool.
Content Validity
The QuEDS was created to answer the following question: Does
it include the most common symptoms related to various types of
MDEs? The FPA methodology was used to answer this question.
A matrix was created with 41 items in the rows and 23 clinical
criteria in the columns, called the “clinical context.” Thus, it was
verified that each itemwould include one ormore clinical criteria.
Four specialists in the field of mood disorders carried out this
analysis. Table 5 shows the content of the items and the set of
attributes (symptoms) that each item investigates.
Concerning content validity, the first key result is that the
QuEDS was able to collect all of the information from 41 items,
in terms of clinical criteria, to evaluate different types of MDEs.
In addition, the items in the table above may include one or
more clinical criterion. The literature and tests frequently used
to assess depression highlight that none of the tests alone is able
to investigate all clinical criteria, even those related to the DSM-5.
Furthermore, in formulating the items, we avoided
methodological problems such as double phrases (“I’m
depressed” or “I often want to cry”), fuzzy adverbs (“my life is
pretty full”), or problems with content validity. In other words,
each item of the QuEDS includes one or more clinical criteria
described in Table 1; none of the items investigate other criteria
or other symptoms that may be related to depression but are not
part of the construct (e.g., items about anxiety, obsessions, etc.).
In the matrix, this means that there were no empty rows (with
all “0”). Also, there were no empty columns in the matrix; from
a conceptual point of view, this means that the 41 items of the
QuEDS investigate all 23 of the clinical criteria in Table 1.
By applying FPA, it became possible to conduct a content
analysis even for the three sub-factor included in the model.
For each factor, it has been possible to create a clinical context
including all of its items and the subset of attributes investigated
by the items of the sub-factor. The results of this procedure are
displayed in Table 6.
It is noteworthy how the sets of attributes investigated by each
factor are different (Table 7). More specifically, only the cognitive
factor investigates feelings of worthlessness and guilt, indecision,
recurrent thoughts of death and suicidal ideation, Beck’s negative
view of the world, and finally health concerns; in fact, all of
these symptoms are related to thoughts. The somatic factor alone
includes decreased interest in sex, increased or loss of weight,
gain or loss of appetite, insomnia or hypersomnia, psychomotor
retardation, fatigue or energy loss, and somatic disorders; all
of these manifestations are physical dysfunctions. Instead, the
affective factor alone comprises diminished interest and pleasure,
irritability, and a more positive mood in the evening. Finally,
some symptoms are investigated by two sub-factors, and one of
them is investigated by all of the sub-factors.
The following table briefly describes the links between the
sub-factors and the attributes (symptoms) that they share.
The strong innovation of FPA comes from the construction
of the matrix, which allows identification of the actual existing
relations between the items and clinical criteria as well as among
the items, in terms of the clinical symptoms they endorse.
Analysis of these relationships allows clinicians to go beyond
the score, acquire qualitative information on the individual,
and understand and analyze the patient’s symptomatic areas in
an adaptive way. A descriptive example about how the FPA
could integrate the quantitative information collected through
the questionnaire is presented below.
Beyond the Numeric Score: The “Clinical State” of
the Patient
As stated before, the new QuEDS allows clinicians to go beyond
the numeric score and focus their analysis on the symptoms that
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TABLE 5 | The items with their attributes.
Items Clinical criteria
1. I feel that I don’t have the same energy to have sex A3, A9
2. I often wake up in the middle of the night and I can’t
asleep again
A6, A7
3. I feel like that my thinking is slowing down A8, A12
4. I have sleeping problems A6
5. I am stressed by feeling of guilt A11
6. I am think the world is cruel and unhappy A16
7. I keep crying very easily A1, A7, A19
8. I get irritated very easily A19
9. I think my life is hell and I only deserve to feel bad A1, A11, A16
10. I fell incapable to face life’s events A18
11. I suffer of somatic disorders (e.g. headache stomach
ache)
A22
12. I have lost interest in the future which doesn’t save
anything good for me
A2, A17
13. I am less interest in sex A3, A20
14. I feel incapable and totally useless A10, A18
15. I see the same unhappiness I have now in the
future
A1, A17
16. My desire to eat is not the same A5
17. I often feel like crying, but I cannot do it A1, A20
18. I cannot have any interest and pleasure in people and
things that before I was interested in
A2, A20
19. I thought to kill my self A14, A15
20. Sometimes I think it would be better if I were dead A14
21. I am really worried about my health A21
22. My weight has had significant changes A4
23. I’ve visibly lost (or gained) weight A4
24. I am afraid of about everything that it will happen to me
because I am not able to do anything
A17, A18
25. I feel like I don’t have any more power over my empty
and sad life
A1, A16, A18
26. My appetite has changed A5
27. To make choices is hard for me A12, A13, A20
28. I feel I ‘m slowing down in my daily routines A8, A9
29. I feel helpless and inhibited facing my incapacity to
concentrate
A12, A20
30. I feel too much on the other people that it would be
better if I killed myself
A10, A11, A14
31. I have not much energy and I feel tired A9
32. I am disappointed of myself and the choices I made A10, A11
33. I have problems in making decisions A13
34. I feel sad A1
35. My ability to think and memorize has been reduced A8, A9, A12
36. I don’t have any interest and desire in doing anything A2
37. I am agitated of the idea that this sadness won’t ever
leave me
A1, A7, A17
38. I feel agitated A7
39. I feel so tired and without any energy that I need help to
wash myself and to get dressed
A8, A9, A18, A20
40. I am better in the evening more than in the morning A23
41. I often feel like a loser A10
patients experience or about which they complain. In fact, the
QuEDS takes into account all of the positive responses of the
subject, which are closely linked to the symptoms through the
FPA (MDE clinical criteria). Clinicians will no longer be bound
to the patient’s score but will be interested in the patient’s clinical
state, which is the set of items to which the patient responded
positively, along with the set of symptoms investigated by those
items. Such information is already present in the items, but it
is hidden by a classical testing methodology that considers the
questionnaire score to be the most relevant output used by the
clinicians.
It may be useful to introduce a practical example from the
patients of this study; two of the 38 patients in the clinical
group mentioned above were chosen who obtained the same
score on the QuEDS: 31. This means that both answered “yes”
to 31 items out of the 41 total items. This score is clearly
high, and the patients—who had already been diagnosed with
MDE—were confirmed to have a depressive symptomatology
with this scoring. However, the two patients did not have exactly
the same disorder. Patient SC was suffering from a reactive
MDE (subsequent to a stressful life event), while patient FG
was suffering from MDE inside bipolar disorder type 1 (see
DSM-5). Many authors (e.g., Koukopoulos and Koukopoulos,
1999; Maj et al., 2003) have shown that MDEs in bipolar
disorder often occur with more agitated features. According
to the classical methodology, the questionnaire’s output is the
same for both patients. In agreement with several other authors
(Wright and Feinstein, 1982; Gibbons et al., 1985; Fava et al.,
2004; Bottesi et al., 2015b; Serra et al., 2015), in this study, it
is assumed that if the two patients had the same score, this
did not mean that they had equal symptomatology (they may
have answered affirmatively to the same number of items but
not to the same items, and the whole symptomatology may be
more serious in one of them). Unlike in the usual methodology,
qualitative information on the two patients’ symptoms was
collected through their clinical state.
Patient SC responded affirmatively to items 1, 3, 5, 6, 10, 12, 13,
14, 15, 16, 17, 18, 20, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34,
35, 36, 39, 40, and 41. Consequently, his clinical state contained
the following symptoms (attributes) in terms of clinical criteria:
A1, A2, A3, A4, A5, A8, A9, A10, A11, A12, A13, A14, A16, A17,
A18, A20, andA23. Patient FG responded affirmatively to items 2,
4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19, 20, 21, 24, 25, 26, 27,
29, 32, 33, 34, 36, 37, 38, 40, and 41. Accordingly his clinical state
contained the following symptoms (attributes) in terms of clinical
criteria: A1, A2, A3, A5, A6, A7, A10, A11, A12, A13, A14, A15,
A16, A17, A18, A19, A20, A21, A22, A23 (to see which criteria
the items are related to, see Tables 1, 5).
The listed attributes of both patients comprise the items they
answered positively. As can be seen, the two patients had two
different clinical states. Specifically, they shared a large number
of attributes (namely, A1, A2, A3, A5, A10, A11, A12, A13,
A14, A16, A17, A18, A20, and A23). This fact indicated that
many of the general characteristics of the disorder presented by
both patients were the same. Nevertheless, each patient presented
some specific characteristics that the other did not share. These
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TABLE 6 | The clinical contexts of QuEDS three factors.
A1 A10 A11 A12 A13 A14 A15 A16 A17 A18 A21
COGNITIVE FACTOR
Item 5 0 0 1 0 0 0 0 0 0 0 0
Item 6 0 0 0 0 0 0 0 1 0 0 0
Item 9 1 0 1 0 0 0 0 1 0 0 0
Item 10 0 0 0 0 0 0 0 0 0 1 0
Item 14 0 1 0 0 0 0 0 0 0 1 0
Item 19 0 0 0 0 0 1 1 0 0 0 0
Item 20 0 0 0 0 0 1 0 0 0 0 0
Item 21 0 0 0 0 0 0 0 0 0 0 1
Item 24 0 0 0 0 0 0 0 0 1 1 0
Item 25 1 0 0 0 0 0 0 1 0 1 0
Item 27 0 0 0 1 1 0 0 0 0 0 0
Item 30 0 1 1 0 0 1 0 0 0 0 0
Item 32 0 1 1 0 0 0 0 0 0 0 0
Item 33 0 0 0 0 1 0 0 0 0 0 0
Item 41 0 1 0 0 0 0 0 0 0 0 0
A3 A4 A5 A6 A7 A8 A9 A12 A18 A20 A22
SOMATIC FACTOR
Item 1 1 0 0 0 0 0 1 0 0 0 0
Item 2 0 0 0 1 1 0 0 0 0 0 0
Item 3 0 0 0 0 0 1 0 1 0 0 0
Item 4 0 0 0 1 0 0 0 0 0 0 0
Item 11 0 0 0 0 0 0 0 0 0 0 1
Item 13 1 0 0 0 0 0 0 0 0 0 0
Item 16 0 0 1 0 0 0 0 0 0 0 0
Item 22 0 1 0 0 0 0 0 0 0 0 0
Item 23 0 1 0 0 0 0 0 0 0 0 0
Item 26 0 0 1 0 0 0 0 0 0 0 0
Item 28 0 0 0 0 0 1 1 0 0 0 0
Item 31 0 0 0 0 0 0 1 0 0 0 0
Item 35 0 0 0 0 0 1 1 1 0 0 0
Item 39 0 0 0 0 0 0 1 0 1 1 0
A1 A2 A7 A12 A17 A19 A20 A23
AFFECTIVE FACTOR
Item 7 1 0 0 0 0 1 0 0
Item 8 0 0 0 0 0 1 0 0
Item 15 1 0 0 0 1 0 0 0
Item 17 1 0 0 0 0 0 1 0
Item 18 0 1 0 0 0 0 1 0
Item 29 0 0 0 1 0 0 1 0
Item 34 1 0 0 0 0 0 0 0
Item 36 0 1 0 0 0 0 1 0
Item 37 1 0 1 0 0 0 0 0
Item 38 0 0 1 0 0 0 0 0
Item 40 0 0 0 0 0 0 0 1
Each row is an item, while each column is a clinical criteria either investigated or not by
the item. Every time an item investigates a specific criterion, the corresponding cell will
contain “1,” (otherwise “0).”
characteristics discriminate between the two clinical conditions
and are crucial for effective treatment. More specifically, patient
SC had the following additional symptoms: A4 “increase or
TABLE 7 | The factors that investigate each single attribute of the clinical
context.
Factors Attributes
All three factors A12
Cognitive and affective A1, A17
Cognitive and somatic A18
Somatic and affective A7, A20
Cognitive A10, A11, A13, A14, A15, A16, A21
Somatic A3, A4, A5, A6, A8, A9, A22
Affective A2, A19, A23
loss of weight,” A8 “psychomotor retardation,” and A9 “fatigue
or energy loss.” On the other hand, patient FG, in addition
to the shared symptoms, presented the following attributes:
A6 “insomnia,” A7 “agitation,” A15 “suicidal ideation,” A19
“irritability,” A21” health concerns,” andA22 “somatic disorders.”
Furthermore, the two patients’ responses to the items of the
three sub-dimensions of the QuEDS (cognitive, somatic, and
affective) were considered. Patient SC responded positively to 12
out of 15 items of the cognitive factor, 11 out of 14 items of the
somatic factor, and 7 out of 12 items of the emotional factor;
in contrast, FG responded positively to 14 out of 15 items of
the cognitive factor, 6 out of 14 items of the somatic factor, and
11 out of 12 items of the affective factor. It has to be stressed,
however, that the mere score to the subscales of the QuEDS,
even if useful to help clinicians in preliminarily understand the
situation of patients, is not sufficient to clearly differentiate the
specific kind of depression characterizing the two patients. In
fact, neither a high score in the affective factor implies an agitated
depression, nor a high score in the somatic factor implies the
presence of an inhibited depression. Such characterizations can
be, on the contrary, easily deduced by the clinical states provided
through the FPA approach. Furthermore, even equal scores to
the same subscale may be due to different clinical states. For
instance, considering the Affective factor, it can be seen that it
contains items conveying rather different clinical information. In
other words, the same score on the same subscale can be attained
even if the collection of attributes presented is slightly different:
consider the response patterns A = 7, 8, 15, 34, 37, 38, 40; and
B = 12, 15, 17, 18, 29, 34, 36. They equally score 7. Nevertheless,
the attributes presented by a patient who endorses the response
pattern A are A1, A7, A17, A19, and A23; while those presented
by a patient with response pattern B are A1, A2, A12, A17, and
A20. Both patients present depressive mood (A1) and Beck’s
negative expectation of the future (A17), but A is more concerned
with irritability and agitation, while B is characterized by apathy.
This analysis allows a better classification of the individual
symptoms’ case, which therefore allows for planning different
pharmacological and psychological treatments for the two
patients. The qualitative differences in symptoms between the
two patients are highly relevant for a correct diagnosis and
for future psychological and pharmacological treatment. It
is noteworthy to observe that doctors sometimes prescribe
antidepressants without carefully analyzing the individual’s
depressive symptoms, yet these drugs can be very dangerous and
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can increase the risk of suicide in people with agitated depression
(Balázs et al., 2006; Baldessarini et al., 2006).
Considering a cognitive behavioral and pharmacological
approach, both patients may need some techniques to identify
and correct their negative automatic thoughts and cognitive
distortions. However, SC showed inhibited symptoms such as
psychomotor retardation and a lack of energy, which might be
linked to reduced activity as well as overlooking one’s duties and
daily responsibilities because of thoughts like “I do not have the
strength” and “I will not make it ever.” A goal of psychological
treatment may be to eliminate the guilt for these disabilities and
to encourage the patient to perform one small task at a time,
while an antidepressantmay be useful as a drug treatment. On the
other hand, patient FG responded to symptoms of restlessness,
including insomnia, irritability, health concerns, agitation, and in
particular, suicidal ideation. FG’s psychotherapeutic intervention
may be more focused on body relaxation and advice on the
conduct of daily life (e.g., avoid excessive working stress and
follow a regular rhythm of life), while the drug therapy may be
in line with bipolar disorder and include mood stabilizers and
sedative drugs to reduce agitated depressive episodes.
Moreover, the proposed methodology even provides
information to clinicians about the possible symptoms of a
person who does not have MDEs and who belongs to the
non-clinical group. To illustrate, MT obtained a score of six to
the questionnaire (the mean of the non-clinical group) after
responding affirmatively to items I1, I11, I13, I27, I31, and I33.
His clinical state was A3, A9, A13, A20, and A22. Even if he did
not show a depressive symptomatology, dysfunctions related
to his sexual desire, his energy, and his indecision emerged
from his clinical state; also, he has somatic complaints. A usual
questionnaire only provides a quantitative score (6), which only
means that MT is not suffering from MDEs. This information
could underline symptoms in common with some other
psychological disorder and could show alarming manifestations,
which occur in a “broad spectrum” evaluation, in which the
clinician understands some crucial symptoms of the subject and
then explores them with more specific and targeted tests.
Therefore, the output of the proposed tool (QuEDS) is the
patient’s clinical state; it is no longer the score. From a clinical
point of view, a qualitative self-report tool overcomes the cutoff
limit, which can be helpful just to have an idea about the test
score, but it cannot be mistaken for a correct estimate of a
person’s symptomatology.
DISCUSSION
According to the DSM-5, there are different types of MDE, and
depressive symptoms may have different features, depending
on the individual and his/her particular disorder. The present
paper was aimed at introducing a new assessment tool capable of
account for the differences among the clinical symptomatology
of patients that are not evaluable using traditional test scores
alone. This task was carried out by using FPA as the theoretical
framework in constructing the tool. Concerning the different
clinical features, some specific illustrations showed how the tool
can be used to more deeply investigate the clinical state of
different patients.
Statistical results confirmed the goodness of the proposed
tool, in terms of both validity and reliability. The high internal
consistency of both the subscales and the whole scale indicates
how the items are coherent in exploring the construct. With
respect to the test-retest reliability, the correlation shows a good
stability of the measure. It has to be noted that, given the 1 month
time interval selected for the retest, this reliability estimate may
not be replicable with participants whose depressive symptoms
are more truly episodic.
Concerning the factor structure, the hierarchical model
explains best the observed data. As shown in the results MDE can
be explained both by the general “depression” factor and by the
three sub-factors (cognitive-somatic and affective), and a patient
may have more somatic symptoms, or more cognitive/affective
symptoms depending on the features of his illness. Also this
aspect may become important for the treatment of the individual
case.
The results of the divergent/convergent validity on the one
hand showed the difference between the correlation of anxiety
subscale (A) of the DASS and QuEDS and the correlation
between the depression subscale (D) of the DASS and QuEDS,
highlighting the convergent validity between the D-scale and
QuEDS; on the other hand, the correlation between the subscale
stress (S) of the DASS and QuEDS showed the presence of
many shared clinical features between the two constructs. It is
noteworthy that especially the affective and somatic sub-factors
of the QuEDS have a high correlation with the scale S. This
result may seem unusual at first, but as the literature suggests
(Hewitt and Flett, 1993; Dumont and Provost, 1999; Tafet et al.,
2001) stress and depression have many symptoms in common,
in particular the people vulnerable to mood disorders are more
sensitive to stress (Bidzi, 1984). Furthermore, the Stress scale
of DASS is sensitive to levels of chronic non-specific arousal.
It assesses difficulty relaxing, nervous arousal, and being easily
upset/agitated, irritable/over-reactive and impatient; all these
symptoms are highly correlated to the affective dimensions, as
our results suggested.
Concerning the content validity, from this new perspective,
the relations among the 41 items and the 23 clinical criteria
play a crucial role. The matrix shows that of the all clinical
criteria are investigated by at least one item. This result is
very important because it means that the presence or absence
of the 23 symptoms selected for describing the MDE can
be detected using the QuEDS. Having information on all of
these symptoms makes it possible to compare the observed
responses of the subject according to the clinical symptoms
he/she demonstrated up to the present. This fact, for instance,
allows for determining whether an individual has more inhibited
symptoms, more agitated ones, or both. Indeed, the set of
items to which the individual responds includes a well-defined
series of clinical criteria, which are useful for a first psycho-
diagnostic examination. Thus, the output of the QuEDS is no
longer crucially related to some sort of cutoff (or score) that
shows whether the person could be classified as suffering from
the disease or not. On the contrary, it consists of qualitative and
Frontiers in Psychology | www.frontiersin.org 11 February 2017 | Volume 8 | Article 214
Serra et al. QuEDS
quantitative information about the patient’s clinical state. Such
output provides the potential capability to go beyond the scores
and investigate the configuration of the patients’ symptoms to
differentiate people who received the same score on the test but
have different symptoms (by responding affirmatively to the same
number of items but not to the same items) and considering when
the whole symptomatology is more serious.
Moreover, unlike many self-report measures in use to assess
MDEs, the QuEDS deeply investigates the symptoms related
to agitated depression, including irritability, insomnia, crying
spells, somatic disorders, and agitation. The investigation the
symptoms related to agitated depression is quite important
because people with agitated depression need completely
different pharmacological and psychological treatments from
those with other types of MDE; for example, antidepressants can
increase the psychomotor agitation and the risk of suicide in
people with agitated depression (Baldessarini et al., 2006; Balázs
et al., 2006).
Another important result obtained by the QuEDS is the
possible future application of an adaptive logic based on the
matrix in Table 6. The reasoning is the same as the semi-
structured interviews (Ferentinos et al., 2011). In a future
direction, the QuEDS will not follow a predetermined sequence
of items, since the items’ order will be presented by a
computerized routing on the basis of the previously collected
answers. Given this procedure, it will probably be unnecessary
to administer the whole test to the subject, but only the items
related to the subject’s replies, deepening the symptomatic areas
while not investigating the areas in which the subject does not
present those specific symptoms. Since we divided the matrix of
41 items into three sub-matrices related to the three sub-factors—
cognitive, somatic, and affective (Table 6). This could be useful
for the future implementation of the three algorithms of the
QuEDS to respond adaptively and individually to the test (the
mathematical steps are beyond the aims of this study; Donadello
et al., 2016).
To summarize, the purpose of this study was to create an
innovative tool that takes into account the weaknesses of the
tests being used and their real potential in the assessment
phase. It is considered that a psychological assessment cannot
be conducted using only self-report tools; rather, effective and
efficient tools to support the diagnosis and treatment are an
integral part of the assessment. As a consequence, our proposed
QuEDS could be a useful contribution for many reasons: first,
for the broad spectrum of clinical criteria investigated by the
test; second, for the importance given to qualitative information
about the symptoms (through the patient’s clinical state) and
not only to the score; third, for the relevance attributed to
the differences in symptoms and especially in their severity;
fourth, for the possible future application of an adaptive
logic; and finally, for its appreciable validity and reliability
results.
AUTHOR CONTRIBUTIONS
FS, AS, MG, and GV: project design; FS and AS: introduction and
discussion writing; FS: participants recruitment and testing; AS,
FS, and GV: data analysis; FS, AS, and MG: methods and results
writing; GV: project supervision.
ACKNOWLEDGMENTS
Authors would like to thank all of the participants who have
kindly given their time to participate in the research. Especially,
the Head of the day hospital service of S. Andrea Hospital (Rome)
Dr. Giovanni Manfredi and all the psychiatrists, and psychiatry
residents of NESMOS Department “La Sapienza” University,
Rome.
REFERENCES
Al Busaidi, Z. Q. (2010). The concept of somatization: a cross-cultural perspective.
Sultan Qaboos Univ. Med. J. 10, 180–186.
Alexopoulos, G. S., Hoptman, M. J., Yuen, G., Kanellopoulos, D., Seirup, J. K., Lim,
K. O., et al. (2013). Functional connectivity in apathy of late-life depression: a
preliminary study. J. Affect. Disord. 149, 398–405. doi: 10.1016/j.jad.2012.11.023
Alloy, L. B., Peterson, C., Abramson, L. Y., and Seligman, M. E. (1984).
Attributional style and the generality of learned helplessness. J. Pers. Soc.
Psychol. 46:681. doi: 10.1037/0022-3514.46.3.681
American Psychiatric Association (2013). Diagnostic and Statistical Manual of
Mental Disorders (DSM-5 R©). Arlington, VA: American Psychiatric Pub.
Balázs, J., Benazzi, F., Rihmer, Z., Rihmer, A., Akiskal, K. K., and Akiskal,
H. S. (2006). The close link between suicide attempts and mixed (bipolar)
depression: implications for suicide prevention. J. Affect. Disord. 91, 133–138.
doi: 10.1016/j.jad.2005.12.049
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., and
Hennen, J. (2006). Decreased risk of suicides and attempts during long-term
lithium treatment: a meta-analytic review. Bipolar Disord. 8(5 Pt 2), 625–639.
doi: 10.1111/j.1399-5618.2006.00344.x
Baldessarini, R. J., Vieta, E., Calabrese, J. R., Tohen, M., and Bowden, C. L.
(2010). Bipolar depression: overview and commentary. Harv. Rev. Psychiatry
18, 143–157. doi: 10.3109/10673221003747955
Balsamo, M., and Saggino, A. (2007). Test per l’assessment della depressione
nel contesto italiano: un’analisi critica. Psicoterap. Cognit. Comportament. 13,
167–199.
Batterham, P. J., Ftanou, M., Pirkis, J., Brewer, J. L., Mackinnon, A. J., Beautrais,
A., et al. (2015). A systematic review and evaluation of measures for suicidal
ideation and behaviors in population-based research. Psychol. Assess. 27,
501–512. doi: 10.1037/pas0000053
Beck, A. T. (1991). Cognitive therapy: a 30-year retrospective. Am. Psychol. 46:368.
doi: 10.1037/0003-066X.46.4.368
Beck, A. T. (2005). The current state of cognitive therapy: a 40-year
retrospective. Arch. Gen. Psychiatry 62:953. doi: 10.1001/archpsyc.
62.9.953
Beck, A. T., Steer, R. A., and Brown, G. K. (1996). Beck Depression Inventory-II. San
Antonio, TX: Psychological Corporation, b9.
Beck, A. T., Steer, R. A., and Carbin, M. G. (1988). Psychometric properties of the
Beck Depression Inventory: twenty-five years of evaluation. Clin. Psychol. Rev.
8, 77–100. doi: 10.1016/0272-7358(88)90050-5
Berrios, R., Kellett, S., Fiorani, C., and Poggioli, M. (2015). Assessment of
identity disturbance: factor structure and validation of the personality structure
questionnaire in an italian sample. Psychol. Assess. 28, 27–35. doi: 10.1037/pas
0000143
Bertolotti, G., Zotti, A. M., Michielin, P., Vidotto, G., and Sanavio, E. (1990). A
computerized approach to cognitive behavioural assessment: an introduction
Frontiers in Psychology | www.frontiersin.org 12 February 2017 | Volume 8 | Article 214
Serra et al. QuEDS
to CBA-2.0 primary scales. J. Behav. Ther. Exp. Psychiatry 21, 21–27.
doi: 10.1016/0005-7916(90)90045-M
Bidzi, E. J. (1984). Stress factors in affective diseases. Br. J. Psychiatry 144, 161–166.
doi: 10.1192/bjp.144.2.161
Blatt, S. J. (2004). Experiences of Depression: Theoretical, Clinical, and
Research Perspectives. Washington, DC: American Psychological Association.
doi: 10.1037/10749-000
Bokhari, E., and Hubert, L. (2015). A new condition for assessing the clinical
efficiency of a diagnostic test. Psychol. Assess. 27, 745–754. doi: 10.1037/pas
0000093
Bottesi, G., Ghisi, M., Altoè, G., Conforti, E., Melli, G., and Sica, C. (2015a). The
Italian version of the Depression Anxiety Stress Scales-21: factor structure and
psychometric properties on community and clinical samples.Compr. Psychiatry
60, 170–181. doi: 10.1016/j.comppsych.2015.04.005
Bottesi, G., Spoto, A., Freeston,M. H., Sanavio, E., and Vidotto, G. (2015b). Beyond
the score: clinical evaluation through formal psychological assessment. J. Pers.
Asses. 97, 252–260. doi: 10.1080/00223891.2014.958846
Campo, J. V. (2012). Annual research review: functional somatic symptoms
and associated anxiety and depression–developmental psychopathology
in pediatric practice. J. Child Psychol. Psychiatry 53, 575–592.
doi: 10.1111/j.1469-7610.2012.02535.x
Carroll, B. J., Feinberg, M., Smouse, P. E., Rawson, S. G., and Greden,
J. F. (1981). The Carroll rating scale for depression. I. Development,
reliability and validation. Br. J. Psychiatry 138, 194–200. doi: 10.1192/bjp.
138.3.194
Cassano, G. B., and Castrogiovanni, P. (1982). SAD, Scala di Autovalutazione Della
Depressione. Milan: International Committee for Prevention and Treatment of
Depression. La Condizione Depressiva. 483–486.
Cortina, J. M. (1993). What is coefficient alpha? An examination of theory and
applications. J. Appl. Psychol. 78, 98–104. doi: 10.1037/0021-9010.78.1.98
Dinger, U., Barrett, M. S., Zimmermann, J., Schauenburg, H., Wright, A. G.,
Renner, and Barber, J. P. (2015). Interpersonal problems, dependency, and
self-criticism in major depressive disorder. J. Clin. Psychol. 71, 93–104.
doi: 10.1002/jclp.22120
Dobson, K. S. (1985). The relationship between anxiety and depression. Clin.
Psychol. Rev. 5, 307–324. doi: 10.1016/0272-7358(85)90010-8
Doignon, J. P., and Falmagne, J. C. (1985). Spaces for the assessment of knowledge.
Int. J. Man Mach. Stud. 23, 175–196. doi: 10.1016/S0020-7373(85)80031-6
Doignon, J. P., and Falmagne, J. C. (1999). Knowledge Spaces. Berlin; Heidelberg:
Springer-Verlag. doi: 10.1007/978-3-642-58625-5
Donadello, I., Spoto, A., Sambo, F., Badaloni, S., Granziol, U., and Vidotto, G.
(2016). ATS-PD: an adaptive testing system for psychological disorders. Educ.
Psychol. Meas. doi: 10.1177/0013164416652188. [Epub ahead of print].
Dumont, M., and Provost, M. A. (1999). Resilience in adolescents: protective
role of social support, coping strategies, self-esteem, and social activities
on experience of stress and depression. J. Youth Adolesc. 28, 343–363.
doi: 10.1023/A:1021637011732
Eaton,W.W., Smith, C., Ybarra,M.,Muntaner, C., and Tien, A. (2004). “Center for
epidemiologic studies depression scale: review and revision (CESD and CESD-
R),” in The Use of Psychological Testing for Treatment Planning and Outcomes
Assessment. Instruments for Adults, 3rd Edn., ed M. E. Maruish (Mahwah, NJ:
Lawrence Erlbaum), 363–377.
Falmagne, J. C., and Doignon, J. P. (2011). “Knowledge spaces,” in Learning Spaces
(Berlin; Heidelberg: Springer), 43–60. doi: 10.1007/978-3-642-01039-2_3
Faravelli, C., Albanesi, G., and Poli, E. (1986). Assessment of depression: a
comparison of rating scales. J. Affect. Disord. 11, 245–253. doi: 10.1016/0165-
0327(86)90076-5
Fava, G. A., Ruini, C., and Rafanelli, C. (2004). Psychometric theory is an
obstacle to the progress of clinical research. Psychother. Psychosom. 73, 145–148.
doi: 10.1159/000076451
Ferentinos, P., Paparrigopoulos, T., Rentzos, M., Zouvelou, V., Alexakis, T., and
Evdokimidis, I. (2011). Prevalence of major depression in ALS: comparison of
a semi-structured interview and four self-report measures. Amyotroph. Lateral
Scler. 12, 297–302. doi: 10.3109/17482968.2011.556744
First, M. B., Spitzer, R. L., Gibbon, M., and Williams, J. B. (1995). Structured
Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P,
Version 2.0). New York, NY: Biometrics Research Department; New York State
Psychiatric Institute.
Ganter, B., and Wille, R. (1999). Formal Concept Analysis: Mathematical
Foundations.Transl. by Cornelia Franzke from the German. Berlin; Heidelberg:
Springer-Verlag. doi: 10.1007/978-3-642-59830-2
Garson, G. D. (2008). Path Analysis from Statnotes: Topics in Multivariate Analysis.
(Retrieved May 5, 2009). Available online at: http://hbanaszak.mjr.uw.edu.pl/
Wnioskowanie%20Statystyczne/09_ZastosowaniaPrzyklady/Garson_2008_
PathAnalysis.pdf
Gibbons, R. D., Clark, D. C., Cavanaugh, S., and Davis, J. M. (1985). Application
of modern psychometric theory in psychiatric research. J. Psychiatr. Res. 19,
43–55. doi: 10.1016/0022-3956(85)90067-6
Goodwin, F. K., and Jamison, K. R. (2007). Manic-Depressive Illness: Bipolar
Disorders and Recurrent Depression. New York, NY: Oxford University Press.
Grossberg, J. M. (1964). Behavior therapy: a review. Psychol. Bull. 62, 73–88.
doi: 10.1037/h0041033
Groth-Marnat, G. (2009). Handbook of Psychological Assessment. Hoboken, NJ:
John Wiley & Sons.
Gunnell, D., and Middleton, N. (2003). National suicide rates as an indicator
of the effect of suicide on premature mortality. Lancet 362, 961–962.
doi: 10.1016/S0140-6736(03)14367-X
Hathaway, S. R., and McKinley, J. C. (1942). A multiphasic personality schedule
(Minnesota): III. The measurement of symptomatic depression. J. Psychol. 14,
73–84. doi: 10.1080/00223980.1942.9917111
Henderson, S. E., Johnson, A. R., Vallejo, A. I., Katz, L., Wong, E., and Gabbay,
V. (2013). A preliminary study of white matter in adolescent depression:
relationships with illness severity, anhedonia, and irritability. Front. Psychiatry
4:152. doi: 10.3389/fpsyt.2013.00152
Henry, J. D., and Crawford, J. R. (2005). The short-form version of the
Depression Anxiety Stress Scales (DASS-21): construct validity and normative
data in a large non-clinical sample. Br. J. Clin. Psychol. 44, 227–239.
doi: 10.1348/014466505X29657
Hewitt, P. L., and Flett, G. L. (1993). Dimensions of perfectionism, daily stress, and
depression: a test of the specific vulnerability hypothesis. J. Abnorm. Psychol.
102:58. doi: 10.1037/0021-843X.102.1.58
House, A. (1989). Hypochondriasis and related disorders: assessment and
management of patients referred for a psychiatric opinion. Gen. Hosp.
Psychiatry 11, 156–165. doi: 10.1016/0163-8343(89)90035-2
Hyman, S. (2014). Mental health: depression needs large human genetics studies.
Nature 515, 189–191. doi: 10.1038/515189a
Jöreskog, K. G. (2006). LISREL. Encyclopedia of Statistical Sciences. John Wiley &
Sons. doi: 10.1002/0471667196.ess1481.pub2
Jöreskog, K. G., and Sörbom, D. (1986). LISREL VI: Analysis of Linear Structural
Relationships by Maximum Likelihood, Instrumental Variables, and Least
Squares Methods.Mooresville, IN: Scientific Software.
Jöreskog, K. G., and Sörbom, D. (1989). LISREL 7: A Guide to the Program and
Applications. Chicago, IL: SPSS.
Jöreskog, K. G., and Sörbom, D. (1993). LISREL 8: Structural Equation Modeling
with the SIMPLIS Command Language. Hillsdale, NJ: Scientific Software
International.
Koukopoulos, A., and Koukopoulos, A. (1999). Agitated depression as a mixed
state and the problem of melancholia. Psychiatr. Clin. North Am. 22, 547–564.
doi: 10.1016/S0193-953X(05)70095-2
Krug, S. E., and Laughlin, J. E. (1976). Handbook for the IPAT Depression
Scale. Champaign, IL: Institute for Personality and Ability Testing. Trad. it.
Questionario di autovalutazione CDQ. Adattamento italiano a cura di M.
Novaga e A. Pedon. Firenze: Organizzazioni Speciali 1979.
Magariños, M., Zafar, U., Nissenson, K., and Blanco, C. (2002).
Epidemiology and treatment of hypochondriasis. CNS Drugs 16, 9–22.
doi: 10.2165/00023210-200216010-00002
Maj, M., Pirozzi, R., Magliano, L., and Bartoli, L. (2003). Agitated depression in
bipolar I disorder: prevalence, phenomenology, and outcome. Am. J. Psychiatry
160, 2134–2140. doi: 10.1176/appi.ajp.160.12.2134
Manea, L., Gilbody, S., and McMillan, D. (2012). Optimal cut-off score for
diagnosing depression with the Patient Health Questionnaire (PHQ-9): a
meta-analysis. CMAJ 184, E191–E196. doi: 10.1503/cmaj.110829
Marsh, H. W., Hau, K. T., and Wen, Z. (2004). In search of golden rules: comment
on hypothesis-testing approaches to setting cutoff values for fit indexes and
dangers in overgeneralizing Hu and Bentler’s (1999) findings. Struct. Equt.
Model. 11, 320–341. doi: 10.1207/s15328007sem1103_2
Frontiers in Psychology | www.frontiersin.org 13 February 2017 | Volume 8 | Article 214
Serra et al. QuEDS
Mulin, E., Leone, E., Dujardin, K., Delliaux, M., Leentjens, A., Nobili, F., et al.
(2011). Diagnostic criteria for apathy in clinical practice. Int. J. Geriatr.
Psychiatry 26, 158–165. doi: 10.1002/gps.2508
O’Hara, M. W., Neunaber, D. J., and Zekoski, E. M. (1984). Prospective study of
postpartum depression: prevalence, course, and predictive factors. J. Abnorm.
Psychol. 93, 158–171. doi: 10.1037/0021-843X.93.2.158
Osborne, J. W., and Costello, A. B. (2004). Sample size and subject to item ratio in
principal components analysis. Pract. Assess. Res. Eval. 9:8.
Pancheri, P., and Carilli, L. (1982). Standardizzazione e validazione di una
nuova self rating-scale per la valutazione della sintomatologia depressiva. Riv.
Psichiatr. 17, 32–37.
Pedrelli, P., Nyer, M., Holt, D., Bakow, B. R., Fava, M., Baer, L., et al. (2013).
Correlates of irritability in college students with depressive symptoms.
J. Nerv. Ment. Dis. 201, 953–958. doi: 10.1097/NMD.00000000000
00038
Pettersson, A., Boström, K. B., Gustavsson, P., and Ekselius, L. (2015). Which
instruments to support diagnosis of depression have sufficient accuracy?
A systematic review. Nord. J. Psychiatry 69, 497–508. doi: 10.3109/080
39488.2015.1008568
Plutchik, R., and Van Praag, H. M. (1987). Interconvertability of five self-report
measures of depression. Psychiatry Res. 22, 243–256. doi: 10.1016/0165-1781
(87)90039-4
Radloff, L. S. (1977). The CES-D scale a self-report depression scale for research
in the general population. Appl. Psychol. Meas. 1, 385–401. doi: 10.1177/01466
2167700100306
Rainone, A., and Mancini, F. (2007). Gli Approcci Cognitivi Alla Depressione, Vol.
35. Milano: FrancoAngeli.
R Core Team (2013). R: A Language and Environment for Statistical Computing.
Vienna: R Foundation for Statistical Computing. Available online at:
http://www.R-project.org/
Roberts, K. E., Hart, T. A., and Eastwood, J. D. (2015). Factor structure and validity
of the state-trait inventory for cognitive and somatic anxiety. Psychol. Assess. 28,
134–146. doi: 10.1037/pas0000155
Roca, R. P., Wigley, F. M., and White, B. (1996). Depressive symptoms
associated with scleroderma. Arthritis Rheum. 39, 1035–1040. doi: 10.1002/art.
1780390623
Sakamoto, S., Kijima, N., Tomoda, A., and Kambara, M. (1998). Factor
structures of the Zung Self-Rating Depression Scale (SDS) for
undergraduates. J. Clin. Psychol. 54, 477–487. doi: 10.1002/(SICI)1097-
4679(199806)54:4<477::AID-JCLP9>3.0.CO;2-K
Sanavio, E., Bertolotti, G., Michielin, P., Vidotto, G., and Zotti, A. M. (1986).
CBA-2.0 Scale Primarie. Firenze: Organizzazioni Speciali, b34.
Schmid, J., and Leiman, J. M. (1957). The development of hierarchical factor
solutions. Psychometrika 22, 53–61. doi: 10.1007/BF02289209
Seligman, M. E. (1972). Learned helplessness. Annu. Rev. Med. 23, 407–412.
doi: 10.1146/annurev.me.23.020172.002203
Serra, F., Spoto, A., Ghisi, M., and Vidotto, G. (2015). Formal psychological
assessment in evaluating depression: a new methodology to build
exhaustive and irredundant adaptive questionnaires. PLoS ONE 10:e0122131.
doi: 10.1371/journal.pone.0122131
Shapiro, M. B. (1951). An experimental approach to diagnostic psychological
testing. J. Mental Sci. 97, 748–764. doi: 10.1192/bjp.97.409.748
Shean, G. D., and Baldwin, G. (2012). The latent structure of the Center for
Epidemiological Studies-Depression scale. J. Psychopathol. Behav. 34, 502–509.
doi: 10.1007/s10862-012-9296-3
Sheehan, D., V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E.,
et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I): the
development and validation of a structured diagnostic psychiatric interview for
DSM-IV and ICD-10. J. Clin. Psychiatry 59, 22–33.
Spoto, A., Bottesi, G., Sanavio, E., and Vidotto, G. (2013). Theoretical foundations
and clinical implications of formal psychological assessment. Psychother.
Psychosom. 82, 197–199. doi: 10.1159/000345317
Spoto, A., Stefanutti, L., and Vidotto, G. (2010). Knowledge space theory, formal
concept analysis, and computerized psychological assessment. Behav. Res.
Methods 42, 342–350. doi: 10.3758/BRM.42.1.342
Subica, A. M., Fowler, J. C., Elhai, J. D., Frueh, B. C., Sharp, C., Kelly, E. L.,
et al. (2014). Factor structure and diagnostic validity of the Beck Depression
Inventory–II with adult clinical inpatients: comparison to a gold-standard
diagnostic interview. Psychol. Assess. 26, 1106–1115. doi: 10.1037/a0036998
Tafet, G. E., Idoyaga-Vargas, V. P., Abulafia, D. P., Calandria, J. M., Roffman, S. S.,
Chiovetta, A., et al. (2001). Correlation between cortisol level and serotonin
uptake in patients with chronic stress and depression. Cogn. Affect. Behav.
Neurosci. 1, 388–393. doi: 10.3758/CABN.1.4.388
Wille, R. (1982). “Restructuring lattice theory: an approach based on hierarchies of
concepts,” in Ordered Sets, ed I. Rival (Dordrecht: Reidel), 445–470.
Wright, J. G., and Feinstein, A. R. (1982). A comparative contrast of clinimetric
and psychometric methods for constructing indexes and rating scales. J. Clin.
Epidemiol. 45, 1201–1218. doi: 10.1016/0895-4356(92)90161-F
Zung, W. W., Richards, C. B., and Short, M. J. (1965). Self-rating depression scale
in an outpatient clinic: further validation of the SDS. Arch. Gen. Psychiatry 13,
508–515. doi: 10.1001/archpsyc.1965.01730060026004
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Serra, Spoto, Ghisi and Vidotto. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Psychology | www.frontiersin.org 14 February 2017 | Volume 8 | Article 214
